Hyperammonemic encephalopathy induced by valproic acid

被引：0
|
作者：
Zhu, Qiuyu M. [1 ]
Singh, Amitosh K. [1 ]
Chang, Huai-En Rachel [1 ]
Konka, Sandeep A. [2 ]
机构：
[1] Kaiser Permanente Mid Atlantic States, Internal Med, Gaithersburg, MD 20879 USA
[2] Mid Atlantic Permanente Med Grp, Hosp Med, Rockville, MD USA
来源：
BMJ CASE REPORTS | 2024年 / 17卷 / 02期
关键词：
Unwanted effects; adverse reactions; Safety; Psychiatry (drugs and medicines); Healthcare improvement and patient safety; Drugs: CNS (not psychiatric); RISK-FACTORS; CARNITINE; LORAZEPAM;
D O I：
10.1136/bcr-2023-257144
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Valproate (VPA) is broad-spectrum antiepileptic drug. Several adverse reactions including hepatotoxicity, fetal risk and pancreatitis are well known and labelled as boxed warnings in the USA. One adverse reaction that is less well known but clinically significant for its severe morbidity is hyperammonemic encephalopathy. We present a case of woman with hyperammonemic encephalopathy following the initiation of VPA therapy; she had a favourable outcome with discontinuation of the drug and prompt treatment with lactulose and L-carnitine.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Valproic acid induced hyperammonemic encephalopathy
    Bek, S.
    Kasikci, T.
    Tokgoz, E.
    Gokcil, Z.
    Odabasi, Z.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 619 - 619
  • [2] Hyperammonemic encephalopathy induced by valproic acid
    Diaz-Rangel, Marca
    Grande-Martin, Alberto
    Monsalve-Naharro, Jose A.
    Domingo-Chiva, Esther
    Cuesta-Montero, Pablo
    Lopez-Perez, Alfonso
    REVISTA DE NEUROLOGIA, 2017, 65 (12) : 574 - 575
  • [3] VALPROIC ACID INDUCED HYPERAMMONEMIC ENCEPHALOPATHY
    Dan, Ansu Anna
    James, Josna
    George, Anjali
    Premkumar, Unnimaya
    Apollojames
    Kumar, T. R. Ashok
    Sivakumar, T.
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 2 (09): : 1248 - 1250
  • [4] Valproic Acid-Induced Hyperammonemic Encephalopathy
    Moustafa, Yara
    Torriente-Crespo, Ivonne
    Dalkilic, Alican
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S143 - S144
  • [5] Valproic acid and zonisamide induced hyperammonemic encephalopathy
    Ilieva, Hristelina S.
    Newman, Joseph W.
    Fields, Ronald K.
    Croom, John E.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2020, 196
  • [6] Valproic acid-induced Hyperammonemic Encephalopathy
    Hocaoglu, Naciye
    Ozsoy, Saliha
    Bulut, Kadir
    Ismailogullari, Sevda
    Erdogan, Mustafa
    DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, 2020, 33 (02): : 218 - 220
  • [7] INCIDENCE OF VALPROIC ACID-INDUCED HYPERAMMONEMIC ENCEPHALOPATHY
    Dominguez Bertalo, J.
    Carrasco, S.
    Burriel, L.
    Alvarez, M. J.
    Gudin, M.
    Vaamonde, J.
    EPILEPSIA, 2011, 52 : 120 - 120
  • [8] Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy
    Mock, Christie M.
    Schwetschenau, Kristen H.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (01) : 35 - 39
  • [9] A Case of Valproic-Acid Induced Hyperammonemic Encephalopathy
    Iqbal, Kinza
    Kummamuru, Hardhik
    Dasari, Naresh
    Koritala, Thoyaja
    Jain, Nitesh K.
    Deepika, Keerti
    Adhikari, Ramesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [10] Valproic acid induced hyperammonemic encephalopathy: A case report
    Apa, Ferda
    Atesci, Figen Culha
    Varma, Gulfizar Sozeri
    KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY, 2018, 21 (01): : 102 - 106
12345